BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

STAAR Surgical Company (STAA) Launches Enhanced Consumer Awareness Initiatives for Visian® ICL


6/27/2012 11:27:23 AM

MONROVIA, Calif., June 27, 2012 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced the launch of enhanced global consumer awareness initiatives for the VisianĀ® ICL product line. The initiatives include a redesigned consumer-friendly web site, increased support for practices and distributors for their own Visian ICL awareness campaigns and added consumer marketing in Asia.

"The Visian ICL has proven to be a very effective alternative to Lasik, and these new programs are designed to educate consumers about the product line's many benefits," said Robin Hughes, Vice President of Global Marketing for STAAR Surgical. "We already know from our work in search engine marketing that consumers are currently coming to us looking for alternatives, and we now have better resources to answer their questions and get them to the best local physicians who can help them. And, we are expanding this program globally."

The redesigned web site will launch tomorrow, June 28, 2012 at www.visianinfo.com and will provide an easier-to-use design including new product pages that educate patients on the Visian ICL option in a clear and comprehensive manner. In addition, www.visianinfo.com will offer:

  • An enhanced surgeon locator, integrated with Google Maps gives consumers direct access to the surgeon who can best help them.
  • A new blog will highlight particular patients and practices monthly. It will offer surgeon interviews as well as question and answer sessions with surgeons.
  • New testimonial pages will be highlighted.
  • A direct connection will exist with the company's Facebook, Twitter and YouTube presence.
  • New refractive options charts will help consumers understand the various options available to correct vision.

Meanwhile STAAR Surgical will enhance its ability to support practices and distributors that are developing their own consumer awareness campaigns. This includes leadership from a new head of STAAR's global online marketing, as well as two new social media coordinators on the company's global team who bring expertise in public health marketing, social campaigns and digital video. Additional consumer marketing employees have been added in China, the Middle East and India with expertise in direct to consumer education programming that will support our distributors and their customers, and a new position will be added to execute social media work in Japan. The Company continues to evaluate new consumer driven initiatives by testing new methods to create consumer demand for individual practices.

"One current example of how we're supporting practices is what we are doing for Dr. Dan Tran in Southern California," said Ryan Black, Online Marketing Manager for STAAR. "This campaign is geared toward a certain segment of his patient base with the use of billboards a traditional marketing tool - supported by on-line efforts and banner ads. It includes continuous testing of display ad effectiveness on the Google Ad Network, and early indications are we are succeeding."

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable CollamerĀ® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 300,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in approximately 50 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at www.staar.com or call 626-303-7902.

CollamerĀ® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material.

CONTACT:

Investors

Media


EVC Group

EVC Group


Douglas Sherk, 415-652-9100

Chris Gale


Jenifer Kirtland, 415-568-9349

646-201-5431

SOURCE STAAR Surgical Company



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES